GE-38 IDENTIFYING THE TREATMENT-RESISTANT MESENCHYMAL SIGNATURE BY COMPARATIVE ANALYSES BETWEEN GLIOMA SPHERE-FORMING CELLS AND THEIR GLIOBLASTOMAS OF ORIGIN

The mesenchymal (Mes) subtype of glioblastoma (MesGBM) correlates with poor patient prognosis. Surprisingly, agents that target mesenchymal tumors, such as the antiangiogenesis drug bevacizumab, failed to show a benefit in MesGBM. The expression of MesGBM might result from both cells from the surrou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Qianghu, Ezhilarasan, Ravesanker, Zheng, Siyuan, Gumin, Joy, Heffernan, Tim, Draetta, Giulio, Lang, Frederick, Verhaak, Roeland, Sulman, Erik
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218203/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou256.37
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados